Springer will launch a new book series in collaboration with the European Association for Predictive, Preventive and Personalised Medicine (EPMA). The first volume in the series Healthcare Overview: New Perspectives will be published at the end of 2012. Approximately three books will be published each year.
The new series Advances in Predictive, Preventive and Personalised Medicine will provide an overview of multidisciplinary aspects of advanced biomedical approaches and innovative technologies in healthcare. Topics will focus on cost-effective management of healthcare tailored to the individual, and innovative strategies for standardization of healthcare services. The books will also include new guidelines for medical ethics, innovative approaches to early and predictive diagnostics, targeted prevention in healthy individuals, and healthcare economy and marketing. Dr. Olga Golubnitschaja of the University of Bonn (Germany) is the editor of the book series.
Dr. Golubnitschaja said, "Innovative predictive, preventive and personalised medicine is emerging as the focal point of efforts in healthcare aimed at curbing the prevalence of common diseases, such as diabetes, cardiovascular diseases, chronic respiratory diseases and cancer, and rare diseases. This new book series is intended to serve as a reference source for researchers and the healthcare industry with a special emphasis on health promotion in the general population."
Martijn Roelandse, Publishing Editor Biomedical Sciences at Springer, said, "Integration of individual professional groups into the overall concept of PPPM is a particular advantage of this book series. The increasing importance of personalised medicine in the field of health is reflected by the fact that the Vice-President of the European Commission, Antonio Tajani, has written the foreword to the first volume of the series."
The mission of the EPMA is to raise awareness and recognition of predictive, preventive and personalised medicine among healthcare stakeholders, governmental institutions, educators, funding bodies, patient organizations and in the public domain. Among its responsibilities are providing and disseminating up-to-date information and educational materials on predictive and personalised medicine and targeted preventive measures, encouraging the adequate allocation of resources in this area and promoting high-quality research in the field. The Society's official journal, The EPMA Journal, is published by BioMed Central, an open access publisher in the Springer group.
Springer Science+Business Media is a leading global scientific publisher, providing researchers in academia, scientific institutions and corporate R&D departments with quality content via innovative information products and services. Springer is also a trusted local-language publisher in Europe – especially in Germany and the Netherlands – primarily for physicians and professionals working in the automotive, transport and healthcare sectors. Roughly 2,000 journals and more than 7,000 new books are published by Springer each year, and the group is home to the world's largest STM eBook collection, as well as the most comprehensive portfolio of open access journals. Springer employs nearly 7,000 individuals across the globe and in 2011 generated sales of approximately EUR 875 million.